Manglam Infra Engineering Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 04, 2026

Key Highlights

The Latest Trading Price of Manglam Infra & Engineering Ltd is ₹ 11.3 as of 02 Apr 15:30 . The P/E Ratio of Manglam Infra & Engineering Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Manglam Infra & Engineering Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 20003 crore on March 2025 to ₹ 20003 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Manglam Infra & Engineering Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of OneSource Specialty Pharma Ltd for the Dec '25 is ₹ 294.97 crore as compare to the Sep '25 revenue of ₹ 378.8 crore. This represent the decline of -22.13% The ebitda of Manglam Infra & Engineering Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of OneSource Specialty Pharma Ltd for the Dec '25 is ₹ 14.86 crore as compare to the Sep '25 ebitda of ₹ 109.53 crore. This represent the decline of -86.43% The net profit of Manglam Infra & Engineering Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -5.55 crore to ₹ -88.7 crore over 7 quarters. This represents a CAGR of 387.29% The Dividend Payout of Manglam Infra & Engineering Ltd changed from 0 % on March 2021 to 0 % on September 2023 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2021 to 0 % on September 2023 . This represents a CAGR of 0.0% over 6 years .

About Manglam Infra & Engineering Ltd

Manglam Infra & Engineering Ltd was originally formed as Partnership Firm in the name and style of 'Manglam Associates' pursuant to Partnership Deed dated February 17, 2010.
The Partnership Firm got converted into Public Limited Company 'Manglam Infra & Engineering Limited' on July 20, 2023, vide Certificate of Incorporation issued by Registrar of Companies, Central Registration Centre. Manglam Infra & Engineering are an infrastructure consultancy company, and their core business is providing project management consultancy services which includes detailed project reports (DPRs), Supervision and quality control (SQC), and operation & maintenance (O & M) for Highways/Roads, Bridges, Tunnels, Buildings/Urban development.
The Company undertake various project independently as well as through Joint ventures and MoUs with other players in this industry.

About OneSource Specialty Pharma Ltd

Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

FAQs for the comparison of Manglam Infra & Engineering Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, Manglam Infra & Engineering Ltd or OneSource Specialty Pharma Ltd?

Market cap of Manglam Infra & Engineering Ltd is 19 Cr while Market cap of OneSource Specialty Pharma Ltd is 16,092 Cr

What are the key factors driving the stock performance of Manglam Infra & Engineering Ltd and OneSource Specialty Pharma Ltd?

The stock performance of Manglam Infra & Engineering Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Manglam Infra & Engineering Ltd and OneSource Specialty Pharma Ltd?

As of April 4, 2026, the Manglam Infra & Engineering Ltd stock price is INR ₹11.3. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹1403.95.

How do dividend payouts of Manglam Infra & Engineering Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of Manglam Infra & Engineering Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.